Unisense FertiliTech A/S Receives CE Mark of Approval for EmbryoScope(TM) Embryo Monitoring System
AARUHS, Denmark, July 6 /PRNewswire/ -- Unisense FertiliTech A/S
( http://www.fertilitech.com ) announces that the EmbryoScope(TM) Embryo
Monitoring System and EmbryoSlide(TM) tray have received CE approval as class
IIa medical devices for use in IVF. Unisense Fertilitech A/S also received
Nanopoint Applies CE Mark to Its cellTRAY(R) Imaging and Microfluidics Systems
HONOLULU, June 15 /PRNewswire/ -- Nanopoint Inc., an award-winning developer of Microfluidics and Live Cell Imaging products, today announced that effective immediately its cellTRAY Imaging System and cellTRAY Fluidics System are available to the European marketplace. Nanopoint's cellTRAY Imaging ...
STAAR Surgical Receives CE Mark Approval for KS-X Preloaded Hydrophobic Acrylic Lens Injector System
MONROVIA, Calif., June 9 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA ), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it has received CE Mark
approval for its KS-X Preloaded Hydrophobic Acrylic Injector for use i...
EarlySense's EverOn(TM) System Receives FDA Clearance and CE Mark Certification
RAMAT GAN, Israel, June 8 /PRNewswire/ -- EarlySense announced today that
its EverOn contact-free patient supervision system has been cleared for
marketing by the U.S. Food and Drug Administration and has received a CE Mark
certification from KEMA, a Dutch notified body, in accordance with the...
Amedica Receives CE Mark for Valeo(TM) Ceramic Spinal Implant System Incorporating CSC Technology
SALT LAKE CITY, May 4 /PRNewswire/ -- Amedica Corporation, an orthopedic implants company focused on silicon nitride ceramic technologies, announced today that it has received a CE (Conformite Europeene) mark
for initial rollout of their spinal intervertebral spacers using novel CSC (cancellous-st...
Mpex Pharmaceuticals Names Mark Wiggins Chief Business Officer
- Wiggins Joins from Biogen Idec -
SAN DIEGO, April 20 /PRNewswire/ -- Mpex Pharmaceuticals, Inc. today announced that Mark
Wiggins has joined the company as Chief Business Officer. Mr. Wiggins comes to Mpex from Biogen Idec, Inc. where he most recently served as Executive Vice President of ...
Immunotherapy-Based Provisional Patents Mark Significant Discovery
Quantum Immunologics announces the filing of two important provisional patent applications
TAMPA, Fla., March 31 /PRNewswire/ -- Quantum Immunologics, Inc. (QI), a Florida-based company specializing in cancer immunotherapy, has recently filed two provisional patent applications relating to th...
SD Canada Announces CE Mark for ThyroChek(R) Adult and NeoNatal Tests
Rapidly growing thyroid test market expands to EU, LATAM and Africa
SAINT JOHN, New Brunswick, March 11 /PRNewswire/ -- Screening Devices Canada, Inc. announces the immediate availability of ThyroChek, the rapid test for elevated TSH, the first clinical indicator of hypothyroidism to countrie...
AcelRx Pharmaceuticals Hires Mark Evashenk as Vice President of Clinical Operations
REDWOOD CITY, Calif., March 6 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. announced today it has hired Mark
Evashenk as Vice President, Clinical Operations. In this new position, Mr. Evashenk will assist in defining developmental strategy, guiding clinical protocol design and study conduct, and ...
Victhom Human Bionics Receives CE Mark for the Neurostep(TM) System, the World's First Fully Implantable Closed-Loop Neuromodulation Therapy for Treatment of Foot Drop
QUEBEC CITY, Feb. 3 /PRNewswire-FirstCall/ - Victhom Human Bionics Inc., "Victhom" (TSX:VHB), announced today that its Neurobionix division has obtained CE Mark
approval for its Neurostep(TM) System, the first ever approval for a closed-loop system (CLS) used on peripheral nerves. CE Mark
Tissue Genesis Applies CE Mark to Its Adult Stem Cell Isolation System
HONOLULU, Nov. 18 /PRNewswire/ -- Tissue Genesis, Inc., an innovator of
advanced tissue engineering and cell therapy solutions, today announced that
effective immediately, the Tissue Genesis Cell Isolation System will be
available to the European marketplace.
The Tissue Genesis Cell Isolat...
Sound Surgical Technologies Welcomes Dr. Mark Schafer as New Chief Technology Officer and Vice President of Research & Development
LOUISVILLE, Colo., Oct. 3 /PRNewswire/ -- Sound Surgical Technologies
LLC, creator of the VASER(R) Lipo System, has recruited internationally
renowned ultrasonic scientist Mark
Schafer, Ph.D. as the company's new
Chief Technology Officer and VP of Research and Development.
"Dr. Schafer is a ...
ITGI Medical Received a CE Mark for its Second Pericardium Covered Stent - AneuGraft(R) - for Tortuous Vessels
OR AKIVA, Israel, September 30 /PRNewswire-FirstCall/ -- ITGI Medical,
Ltd. (TASE: ITGI) a company engaged with research, development,
manufacturing and marketing of heterologous tissue covered stents,
announced that its second heterologous tissue covered stent - AneuGraft(R)
received CE Mark
Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
VANCOUVER, Aug. 12 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,
Inc. (NASDAQ: ANPI , TSX: ANP), a global specialty pharmaceutical and
medical device company, today announced that it has received CE Mark
approval to begin marketing the HemoStream(TM) Chronic Dialysis Catheter in
Tengion Appoints Mark Stejbach Vice President of Marketing & Commercial Planning
EAST NORRITON, Pa., July 23 /PRNewswire/ -- Tengion Inc., a clinical
stage biotechnology company focused on the development of neo-organs and
neo-tissues, today announced that it has appointed Mark
Stejbach as Vice
President, Marketing and Commercial Planning. Mr. Stejbach brings more than
The TPAA Names Mark Oelschlager President
ATLANTA, July 16 /PRNewswire/ -- The Third Party Administrators
Alliance (TPAA) announced today the appointment of Mark
Oelschlager as its
president. The TPAA is the nation's first alliance of third party
administrators and provides lead generation programs, marketing tools and
PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer
BOSTON, July 16 /PRNewswire-FirstCall/ -- PAREXEL International
Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services
organization, announced today that it has promoted Mark
A. Goldberg, M.D.,
to Chief Operating Officer (COO). Dr. Goldberg previously served as
President of ...
Samarion CEO Mark Rodgers Named CAST Commissioner
Rodgers Will Help Lead Charge for Center for Aging Services Technologies
(CAST) to Expedite Emerging Technologies Transforming the Aging Experience
WASHINGTON, July 15 /PRNewswire/ -- Samarion CEO Mark
recently named commissioner to the Center for Aging Services Technologies
Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
SAN DIEGO, July 14 /PRNewswire-FirstCall/ -- Cardium Therapeutics
(Amex: CXM ) and its operating unit InnerCool Therapies, Inc., announced
today that InnerCool's RapidBlue(TM) endovascular temperature modulation
system conforms to the European Union CE Mark
requirements for use in
ThermoGenesis Announces Receipt of CE Mark for MarrowXpress(TM)
Approval Allows Company to Begin Commercial Sales of Device in Europe
RANCHO CORDOA, Calif., June 19 /PRNewswire-FirstCall/ -- ThermoGenesis
Corp. (Nasdaq: KOOL ), a leading supplier of innovative products and
services that process and store adult stem cells, today announced TUV has
Diffusion Pharmaceuticals Announces Addition of Mark T. Giles to its Board of Directors
CHARLOTTESVILLE, Va., June 10 /PRNewswire/ -- Diffusion Pharmaceuticals
LLC, a clinical-stage drug-development company commercializing new drugs
for the treatment of life-threatening unmet medical needs, today announced
the addition of Mark
T. Giles to its Board of Directors.
Dilon Technologies Receives CE Mark for Medical Imaging System
Gamma Camera sales to be launched in Europe
NEWPORT NEWS, Va., May 6 /PRNewswire/ -- Dilon Technologies announced
today that it has received CE Mark
(Conformite Europeenne) approval for the
commercial sale of the Dilon 6800 Gamma Camera in European Union member
countries. The Dil...
BioMed Realty Trust Announces Retirement of Mark Riedy From Its Board of Directors
SAN DIEGO, April 15 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc.
(NYSE: BMR ) today announced that Mark
Riedy will retire from its board of
directors concurrently with the company's annual meeting of stockholders,
scheduled for May 21, 2008.
Dr. Riedy, the Ernest W. Hahn Professor of...
ES Vascular Receives CE Mark for its First Aortic Stapler for End-to-End Anastomosis Between Synthetic Grafts and Aorta During Open Repair of Aortic Aneurysmal and Occlusive Disease
HAIFA, Israel, April 14 /PRNewswire/ -- ES Vascular Ltd. announced
today that it has received a CE Mark
approval for its Open Aortic Stapler
(OAS) system for mechanical suturing technology of aortic synthetic grafts
during open repair of AAA and other aortic reconstructions, enabling
Kingfisher Healthcare Receives European CE Mark for Next Generation Wound Healing Device
Innovative Device Utilizes Revolutionary Electrotherapy to Improve Healing of Chronic Wounds
ALBUQUERQUE, New Mexico, March 12 /PRNewswire/ -- Kingfisher Americas,
a healthcare company focused on improving patient quality of life, today
announced that its parent compan...
Dr. Mark Nestor Presents on Pyratine-6(TM) at the South Beach Symposium
NAPA, Calif., Feb. 21 /PRNewswire-FirstCall/ -- Senetek PLC (OTC
Bulletin Board: SNKTY), a Life Sciences company engaged in the development
of technologies that target the science of healthy aging, today announced
that Dr. Mark
Nestor presented on Pyratine-6(TM) at the 6th Annual South
FCP Welcomes Mark Scherling
PHOENIX, Feb. 18 /PRNewswire/ -- First Choice Professionals, LLC.,
today announced the addition of Mark
Scherling to its expanding
Applications Services business unit. Mark
will join FCP as Program
Management Office and Siemens Practice Director.
brings thirteen years of Healthcare IT t...
AGA Medical Corporation Receives European CE Mark Approval for the AMPLATZER(R) Duct Occluder II
MINNEAPOLIS, Feb. 11 /PRNewswire/ -- AGA Medical Corporation ("AGA")
announced today it received European CE Mark
approval for the AMPLATZER(R)
Duct Occluder II ("ADO II"). AGA also announced the immediate availability
and launch of the device in Europe. The ADO II expands the AGA family of
Tryton Medical Receives CE Mark Approval for its Side-Branch Stent
Tryton's revolutionary Side Branch Stent obtains CE Mark
approval based on unprecedented results in the Tryton 1 (First-in-Man Study) with No Side-Branch Restenosis in 30 patients.
NEWTON, Mass., Feb. 4 /PRNewswire/ -- Tryton Medical, Inc., the leading
developer of stents desi...
Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System
SINGAPORE, Jan. 18 /PRNewswire/ -- International Group, Ltd.
(Bloomberg: BIG SP, Company or Biosensors), today announced that the
Company has received Conformite Europeenne (CE) Mark
approval for its
BioMatrix(R) drug-eluting stent system, enabling commercialization of this
product in the Euro...
Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)
Only Product of its Kind in Europe to Offer up to Six Months of Pain Relief in OA Knee Pain
CAMBRIDGE, Mass., Dec. 19 /PRNewswire-FirstCall/ -- Genzyme Corp.
(Nasdaq: GENZ ) announced today that it has been granted European approval
through a CE mark
Biomerica Introduces a New 15 Minute Home Test for Allergies to Cats and Receives CE Mark Approval for Home Use
NEWPORT BEACH, Calif., Dec. 18 /PRNewswire-FirstCall/ -- Biomerica,
Inc. (OTC Bulletin Board: BMRA) has introduced a new 15 minute home test
for allergies to cats and announced that it received CE mark
market and sell the product directly to consumers through drug stores in
Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
SEATTLE, Dec. 7 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq:
DNDN) today announced that the Company has promoted Mark
Frohlich, M.D. to
the position of senior vice president of clinical affairs and chief medical
officer. Dr. Frohlich, a urologic oncologist with over a decade of onco...
Diamics Receives European CE Mark Approval for Its Pap-Map(TM) System for Cervical Cancer Screening
NOVATO, Calif., Oct. 29 /PRNewswire/ -- Diamics announced today that it
has received the European CE Mark
(Conformite Europeene) approval for its
Pap-Map(TM) System for cervical cancer screening. The CE Mark
that the product has met EU health, safety and environmental requirements
Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
VANCOUVER, Oct. 11 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,
Inc. (NASDAQ: ANPI , TSX: ANP), a global specialty pharmaceutical and
medical device company, today announced that it has received CE Mark
approval to begin marketing the Quill(TM) Self-Retaining System (SRS)
Basic Scientist Mark Roth Wins MacArthur Fellowship
Cell biologist receives $500,000 'genius award' with 'no strings attached'
SEATTLE, Sept. 25 /PRNewswire/ -- Mark
Roth, Ph.D., a cell biologist at
Fred Hutchinson Cancer Research Center, is among 24 recipients of this
year's MacArthur Fellowships, a "genius" award given annually by the John
Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
BASKING RIDGE, N.J., Sept. 12 /PRNewswire-FirstCall/ -- Millennium
Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG) announced today that
Mark C. Mirken has been elected President and Chief Operating Officer of
Millennium and its subsidiary Millennium Biotechnologies, Inc. Mr. Mirken
Cardica Receives European CE Mark for C-Port Flex A System for Use in Coronary Artery Bypass Surgery
Flex A System Facilitates Minimally Invasive and Robotic-Assisted Coronary Artery Bypass Surgery
REDWOOD CITY, Calif., Sept. 12 /PRNewswire-FirstCall/ -- Cardica, Inc.
(Nasdaq: CRDC ) today announced that it has received European CE Mark
(Conformite Europeenne) approval...
Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-based Instrument, the Barocycler NEP2320
WEST BRIDGEWATER, Mass., Sept. 5 /PRNewswire-FirstCall/ -- Pressure
BioSciences, Inc. (Nasdaq: PBIO ) today announced that it has received
approval to CE Mark
the Barocycler NEP2320, a patent-pending, lightweight,
compressed air driven pressure cycling technology (PCT) instrument. The
AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
MINNEAPOLIS, Aug. 24 /PRNewswire/ -- AGA Medical Corporation ("AGA")
announced today that it has received U.S. Food and Drug Administration
(FDA) and European CE Mark
approvals for the AMPLATZER Vascular Plug II
("vascular plug II"). The AMPLATZER Vascular Plug II expands the AGA family of oc...